" The results must be taken with caution, particularly since the PI has taken liberties in defining these responses, to put it gently. Also, it would be nice to know which dose led to the best response.
In summary, this does not appear to be the "cure" for MF, but it is a promising program. There will be plenty of work ahead for Geron. Manufacturing scale of imetelstat will be no easy task given the complexity of the drug and the process by which it is made. We expect Geron will seek to raise over $100 million in the near future."
In other words.....if you bought the hyped up pop yesterday, you're stuck with huge losses for what will seem like an eternity. GERN has a history of releasing "promising" results and then dumping huge amounts of shares into retail investors' hands in order to fund their continuing cash burning machine that is Geron.